Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02351700 : Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
PhasePhase 4
AgesMin: 18 Years Max: 79 Years
Eligibility
Inclusion Criteria:

- Adult patient undergoing ENTS surgery for resection of pituitary tumor.

- Adults >18 years and <80 years of age.

- English speaking and literate or able to understand the use of a pain scale.

- Body Mass Index >19 and <40 kg/m2

Exclusion Criteria:

- Renal failure (acute or chronic) or creatinine >2.0

- Allergy or intolerance to acetaminophen, ibuprofen, or opioids

- Pre-operative opioid tolerance, dependence, or abuse

- Anaphylaxis to opioids

- History of peptic ulcer disease or recent gastrointestinal bleed requiring surgery

- Cirrhosis, hepatitis, liver transplant, or liver function studies out of normal
range, defined as aspartate aminotransferase (AST)/alanine aminotransferase
(ALT)/bilirubin> 3x upper limit of normal range

- Subject unwilling or unable to sign informed consent for the study

- Pregnancy

- Incarcerated patients
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02351700      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740